Evidium

Evidium

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://evidium.com

Last Round

Series A

Nov 10, 2025

Total Funding Raised

$22M

Company Overview

Evidium is a healthcare technology company that provides a neurosymbolic AI platform to transform clinical knowledge into computational models for care delivery and insurance environments.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Healthcare Analytics, InsurTech, ML Platforms

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Infrastructure

Keywords

neurosymbolic AImedical AIreferenced AIexplainable AIknowledge-grounded LLMsKG-LLMsXAIhealthcare AI infrastructureclinical decision supportprobabilistic forecastingcomputational medicineretrieval-augmented generationRAGmedical risk modelingpayer solutionsutilization managementquality measurementprior authorization automationpayvider solutions

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Evidium Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Evidium Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series ANov 10, 2025

Key People

Founding team and executive leadership

Carl Bate

Founder CEO

Founding Team

Sean Thomas

Chief Product Officer

Executive Team

Evidium Investors

Notable investors and investment history

InvestorRounds
Health2047Series A
Interwoven VenturesSeries A
WGG PartnersSeries A
Mindset VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 20, 2026

    Developing a computational medical intelligence layer for healthcare.

Evidium Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Evidium Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Evidium's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range31
Year Founded2021
Last FundingNov 10, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.